Stock Report

Suven Life Sciences Ltd reports consolidated loss of Rs. 12.68 crores in Q2 FY2024

Posted On : 2023-11-05 16:12:00( TIMEZONE : IST )

Suven Life Sciences Limited has reported Consolidated financial results for the period ended September 30, 2023.

Financial Results (Q2 FY2024) - QoQ Comparison

The company has reported total income of Rs. 8.2013 crores during the period ended September 30, 2023 as compared to Rs. 9.4369 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs. -12.6802 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. -24.0905 crores for the period ended June 30, 2023.

The company has reported EPS of Rs. -0.58 for the period ended September 30, 2023 as compared to Rs. -1.10 for the period ended June 30, 2023.

Financials	Q2 FY2024	Q1 FY2024	% Change
Total Income	₹ 8.2013 crs	₹9.4369 crs	-13.09%
Net Profit	₹-12.6802 crs	₹-24.0905 crs	47.36%
EPS	₹-0.58	₹-1.10	47.27%

Financial Results (Q2 FY2024) - YoY Comparison

The company has reported total income of Rs. 8.2013 crores during the period ended September 30, 2023 as compared to Rs.4.5926 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.-12.6802 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.-23.1815 crores for the period ended September 30, 2022.

The company has reported EPS of Rs.-0.58 for the period ended September 30, 2023 as compared to Rs.-1.59 for the period ended September 30, 2022.

Financials	Q2 FY2024	Q2 FY2023	% Change
Total Income	₹ 8.2013 crs	₹4.5926 crs	78.58%
Net Profit	₹-12.6802 crs	₹-23.1815 crs	45.30%
EPS	₹-0.58	₹-1.59	63.52%

Financial Results (Half Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.17.6382 crores during the 6 Months period ended September 30, 2023 as compared to Rs.8.5676 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.-36.7707 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.-39.5077 crores for the 6 Months period ended September 30, 2022.

The company has reported EPS of Rs.-1.69 for the 6 Months period ended September 30, 2023 as compared to Rs.-2.72 for the 6 Months period ended September 30, 2022.

Financials	Half Year Ended FY2024	Half Year Ended FY2023	% Change
Total Income	₹17.6382 crs	₹8.5676 crs	105.87%
Net Profit	₹-36.7707 crs	₹-39.5077 crs	6.93%
EPS	₹-1.69	₹-2.72	37.87%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 78.31 as compared to the previous close of Rs. 76.17. The total number of shares traded during the day was 44914 in over 519 trades.

The stock hit an intraday high of Rs. 79.74 and intraday low of 75.74. The net turnover during the day was Rs. 3461616.00.